Feedback / Questions
neldaleucel (MT-601) - Marker Therap
https://www.globenewswire.com/news-release/2024/12/19/2999831/0/en/Marker-Therapeutics-Provides-a-Clinical-Update-on-MT-601-in-Patients-with-Lymphoma.html
Dec 19, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next